Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $1.32 Million - $1.51 Million
-8,281 Reduced 82.51%
1,755 $319,000
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $94,806 - $106,774
689 Added 7.37%
10,036 $1.56 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $719,515 - $832,944
-5,386 Reduced 36.56%
9,347 $1.39 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $67,580 - $84,099
-510 Reduced 3.35%
14,733 $1.98 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $20,534 - $23,648
-142 Reduced 0.92%
15,243 $2.43 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $163,482 - $196,058
-1,182 Reduced 7.13%
15,385 $2.49 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $117,970 - $135,304
879 Added 5.6%
16,567 $2.22 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $98,673 - $125,446
-717 Reduced 4.37%
15,688 $2.4 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $92,386 - $114,625
-700 Reduced 4.09%
16,405 $2.66 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $104,851 - $132,667
976 Added 6.05%
17,105 $2.32 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $187,902 - $213,297
1,766 Added 12.3%
16,129 $1.74 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $1,472 - $1,640
-14 Reduced 0.1%
14,363 $1.62 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $64,755 - $71,288
633 Added 4.61%
14,377 $1.56 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $467,163 - $630,720
5,804 Added 73.1%
13,744 $1.47 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $23,109 - $27,123
269 Added 3.51%
7,940 $695,000
Q2 2020

Aug 19, 2020

SELL
$73.37 - $98.18 $54.7 Million - $73.2 Million
-745,468 Reduced 98.98%
7,671 $753,000
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $54.9 Million - $73.5 Million
748,748 Added 17051.88%
753,139 $8,000
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $283,219 - $429,395
4,391 New
4,391 $335,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Laidlaw Wealth Management LLC Portfolio

Follow Laidlaw Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laidlaw Wealth Management LLC with notifications on news.